Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Titel:
Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
Auteur:
Alinari, Lapo Yu, Bo Christian, Beth A. Yan, Fengting Shin, Jungook Lapalombella, Rosa Hertlein, Erin Lustberg, Mark E. Quinion, Carl Zhang, Xiaoli Lozanski, Gerard Muthusamy, Natarajan Prætorius-Ibba, Mette O'Connor, Owen A. Goldenberg, David M. Byrd, John C. Blum, Kristie A. Baiocchi, Robert A.